Letrozole Superior To Tamoxifen In Breast Cancer
Links shared publicly online about this topic.
- 1,507total visits
Letrozole Superior To Tamoxifen In Breast Cancer
View full resource at medicalnewstoday.com
Tags: Cancer, Breast Cancer, Breast Cancer Medication, Women's Health, Femara
Most Recently Shared on December 24, 2009 at 12:14 pm By:
#health_news Letrozole Superior To Tamoxifen In Breast Cancer: The aromatase inhibitor letrozole (F.. http://bit.ly/938bBx
Oncology Medical Article | Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer
mdlinx.com — “Oncology Medical Article: Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer” View full resource at mdlinx.com
Most Recently Shared on March 14, 2012 at 7:36 am By:
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast c... http://t.co/1vtehUEb #oncology
NCI Cancer Bulletin for November 1, 2011 - National Cancer Institute
cancer.gov — “NCI Cancer Bulletin for November 1, 2011 - National Cancer Institute” View full resource at cancer.gov
Most Recently Shared on November 2, 2011 at 1:33 pm By:
Annual screening with chest x-ray does not reduce lung cancer deaths http://t.co/uXEj5DBp
Letrozole Surpasses Tamoxifen at Reducing Breast Cancer Recurrence - NYTimes.com
nytimes.com — “The drug letrozole reduces the chances that a woman’s breast cancer will return and improves her odds of survival to a greater degree than tamoxifen, a study shows.” View full resource at nytimes.com
Most Recently Shared on October 24, 2011 at 5:38 pm By:
Vital Signs: Letrozole Surpasses Tamoxifen at Reducing Breast Cancer Recurrence http://t.co/A63GfCwG
Breast Cancer Survival: Femara Better Than Tamoxifen
webmd.com — “Older women with early breast cancers have fewer recurrences and significantly longer survival times when they take the aromatase inhibitor Femara (letrozole) instead of tamoxifen, a long-term follow-up study shows.” View full resource at webmd.com
Most Recently Shared on October 21, 2011 at 8:58 pm By:
Breast Cancer Survival: Femara Better Than Tamoxifen: Older women with early breast cancers have fewer recurrenc... http://t.co/Wkw0t9jr
Study confirms tamoxifen is superior to fulvestrant in blocking estrogen
news-medical.net — “For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer.” View full resource at news-medical.net
Most Recently Shared on August 19, 2011 at 12:56 pm By:
Study confirms tamoxifen is superior to fulvestrant in blocking estrogen: For the first time, researchers at Sea... http://t.co/4vHE2zs
BIG 1-98: Adjuvant letrozole reduced risk for death, recurrence compared with tamoxifen | HemOncToday
hemonctoday.com — “Further analysis from the phase 3 BIG 1-98 trial showed that women with breast cancer assigned to letrozole had superior 5-year OS and were l” View full resource at hemonctoday.com
Most Recently Shared on March 14, 2011 at 2:11 pm By:
BIG 1-98: Adjuvant letrozole reduced risk for death, recurrence compared with tamoxifen http://bit.ly/gbXJAl
Long-term ATAC results confirm superior efficacy, safety of anastrozole vs. tamoxifen for early breast cancer | HemOncToday
hemonctoday.com — “The 10-year follow-up results of the ATAC trial have confirmed the superior efficacy and safety of the aromatase inhibitor anastrozole compar” View full resource at hemonctoday.com
Most Recently Shared on November 29, 2010 at 9:23 pm By:
Long-term ATAC results confirm superior efficacy, safety of anastrozole vs. tamoxifen for early breast cancer http://bit.ly/hztbGk
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial : The Lancet Oncology
thelancet.com — “Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. By - Prof Jack Cuzick PhD, Ivana Sestak PhD, Prof Michael Baum MD, Prof ...” View full resource at thelancet.com
Most Recently Shared on November 29, 2010 at 6:24 pm By:
Breast Cancer. AI: superior to Tamoxifen 10 years later. http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(10)70257-6/abstract
Oncology Medical News about Breast Neoplasms Postmenopause Tamoxifen Chemotherapy, Adjuvant
mdlinx.com — “Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial” View full resource at mdlinx.com
Most Recently Shared on April 14, 2010 at 9:17 am By:
Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in... http://bit.ly/bvUF4E #oncology
BIG 1-98: Benefits of letrozole over tamoxifen greater than previously reported | HemOncToday
hemonctoday.com — “San Antonio Breast Cancer Symposium</P” View full resource at hemonctoday.com
Most Recently Shared on December 14, 2009 at 2:18 pm By:
#SABCS BIG 1-98: Benefits of letrozole over tamoxifen greater than previously reported http://ow.ly/LT9z
NEJM -- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
content.nejm.org — “Original Article from The New England Journal of Medicine -- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer” View full resource at content.nejm.org
Most Recently Shared on August 20, 2009 at 6:14 pm By:
BIG 1-98 data, originally presented at SABCS http://ow.ly/kKjl, published today in #NEJM: letrozole superior to tamoxifen http://ow.ly/kKkj
Medical News: Sequential Strategy No Help in Early Breast Cancer - in Hematology/Oncology, Breast Cancer from MedPage Today
medpagetoday.com — “For postmenopausal women with endocrine-responsive early breast cancer, a sequence of letrozole (Femara) and tamoxifen holds no advantage over letrozole alone, although it may be better than tamoxifen” View full resource at medpagetoday.com
Most Recently Shared on August 19, 2009 at 11:36 pm By:
Sequential Strategy No Help in Early Breast Cancer (CME/CE) http://ow.ly/15LFtb
Newer Drug Beats Tamoxifen for Older Breast Cancer Patients - Drugs.com MedNews
drugs.com — “For postmenopausal women with breast cancer, treatment with the drug letrozole (Femara) increases survival after surgery more than the widely used tamoxifen, a ” View full resource at drugs.com
Most Recently Shared on August 19, 2009 at 10:48 pm By:
Newer Drug Beats Tamoxifen for Older Breast Cancer Patients - http://bit.ly/F9isS
Health Articles, Tips & News | Newer Drug Beats Tamoxifen for Older Breast Cancer Patients (HealthDay)
healtharticles.ws — “HealthDay - WEDNESDAY, Aug. 19 (HealthDay News) -- For postmenopausal women with breast cancer, treatment with the drug letrozole (Femara) increases survival after surgery more than the widely used tamoxifen, a new study confirms.” View full resource at healtharticles.ws
Most Recently Shared on August 19, 2009 at 9:39 pm By:
@health_articles Newer Drug Beats Tamoxifen for Older Breast Cancer Patients (HealthDay) http://bit.ly/19w2cP
Advertisement

